Mathematics reveals genetic pattern of tumor growthJune 25, 2007Using mathematical theory, UC Irvine scientists have shed light on one of cancer's most troubling puzzles - how cancer cells can alter their own genetic makeup to accelerate tumor growth. The discovery shows for the first time why this change occurs, providing insight into how cancerous tumors thrive and a potential foundation for future cancer treatments. UCI mathematicians Natalia Komarova, Alexander Sadovsky and Frederic Wan looked at cancer from the point of view of a tumor and asked: What can a tumor do to optimize its own growth? They focused on the phenomenon of genetic instability, a common feature of cancer in which cells mutate at an abnormally fast rate. These mutations can cause cancer cells to grow, or they can cause the cells to die. The scientists found that cancerous tumors grow best when they are very unstable in early stages of development and become stable in later stages. In other words, tumors thrive when cancerous cells mutate to speed up malignant transformation, and then stay that way by turning off the mutation rate. The study appeared this week in the Royal Society journal Interface. "Mathematical theory can help us understand cancer," said Komarova, associate professor of mathematics at UCI. "If we know what cancer is doing, we might be able to find ways to fight it." Previous studies have observed this genetic pattern by using laboratory techniques, but the UCI research is the first to explain why the pattern leads to tumor growth. The occurrence of genetic instability is often debated by cancer scientists, some of whom believe that cancer feeds on this instability and others who believe it is a side-effect of the cancer itself. To determine the pattern of genetic changes that leads to the most robust tumor growth, Komarova and her colleagues used a mathematical technique called optimal control theory in which they considered a tumor with set characteristics, then changed the cell mutation variable to see under which circumstances the tumor grew best. "The mutation rate serves as the control knob. Then, we can calculate mathematically how long it takes a tumor with given parameters to reach a certain size," Komarova said. "We found that at early stages of tumor growth, instability is advantageous, and later on it becomes an impediment. This explains why many tumors exhibit a high level of instability at first, and become stable later in their development." This research was supported by a Sloan Fellowship and grants from the National Institutes of Health. The University of California, Irvine |
|||||||||||||||||||||
| Related Tumor Growth Current Events and Tumor Growth News Articles 1930s drug slows tumor growth Drugs sometimes have beneficial side effects. A glaucoma treatment causes luscious eyelashes. A blood pressure drug also aids those with a rare genetic disease. Early-stage, HER2-positive breast cancer patients at increased risk of recurrence Early-stage breast cancer patients with HER2 positive tumors one centimeter or smaller are at significant risk of recurrence of their disease, compared to those with early-stage disease who do not express the aggressive protein, according to a study led by researchers at The University of Texas M. D. Anderson Cancer Center. Researchers use drug-radiation combo to eradicate lung cancer Researchers at UT Southwestern Medical Center have eliminated non-small cell lung (NSCL) cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation. Alternatively spliced tissue factor identified as promising new biomarker for aggressive cancers A recently discovered form of the protein that triggers blood clotting may play a key role in the molecular mechanisms leading to the growth of certain metastatic cancers, according to new research reported by an international team of scientists. Sensor biochips could aid in cancer diagnosis and treatment It is very difficult to predict whether a cancer drug will help an individual patient: only around one third of drugs will work directly in a given patient. Bioluminescence imaging used for eye cancer detection At the moment, doctors rely on biopsy analysis to determine the progression of eye cancer. However, researchers now believe that a new technology, bioluminescence imaging (BLI), will allow doctors to detect tumors earlier and quickly choose a method of treatment that doesn't necessarily involve eye surgery. Novel polymer delivers genetic medicine, allows tracking Theresa M. Reineke, associate professor of chemistry in the College of Science, and colleagues in her lab at Virginia Tech and at the University of Cincinnati have developed a new molecule that can travel into cells, deliver genetic cargo, and packs a beacon so scientists can follow its movements in living systems. NEDD9 Protein Supports Growth of Aggressive Breast Cancer Researchers at Fox Chase Cancer Center have demonstrated that a protein called NEDD9 may be required for some of the most aggressive forms of breast cancer to grow. Their findings, based on the study of a mouse model of breast cancer, are presented in a recent issue of Cancer Research, available on-line now. Experimental drug lets B cells live and lymphoma cells die An investigative drug deprived non-Hodgkin lymphoma cells of their ability to survive too long and multiply too fast, according to an early study published recently in the journal Experimental Hematology. Killing Cancer Like a Vampire Slayer Like vampires, cancer tumors require an ample supply of blood to stay alive. Without fresh blood for sustenance, cancer cells shrivel up like raisins and die. More Tumor Growth Current Events and Tumor Growth News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||